Context
Germline CDKN1B pathogenic variants result in Multiple Endocrine Neoplasia type 4, an autosomal dominant hereditary tumor syndrome variably associated with primary hyperparathyroidism, pituitary adenoma and duodenopancreatic neuroendocrine tumors.
Objective
To report the phenotype of three unrelated cases each with a unique germline CDKN1B variant (of which two are novel) and compare these cases to those described in the current literature.
Design/Methods
Three case studies, including clinical presentation, germline and tumor genetic analysis and family history.
Setting
Two tertiary University Hospitals in Sydney, NSW, and one tertiary University Hospital in Canberra, ACT, Australia.
Outcome
Phenotype of the three cases and their kindred; molecular analysis and tumor p27 kip1 immunohistochemistry.
Results
Family A: the proband developed multiglandular primary hyperparathyroidism, a microprolactinoma and a multifocal non-functioning duodenopancreatic neuroendocrine tumor (DP-NET). Family B: the proband was diagnosed with primary hyperparathyroidism from a single parathyroid adenoma. Family C: the proband was diagnosed with a non-functioning pituitary microadenoma and ectopic Cushing’s syndrome from an atypical thymic carcinoid tumor. Germline sequencing in each patient identified a unique variant in CDKN1B, two of which are novel (c.179G>A, p.Trp60*; c.475G>A, p.Asp159Asn;) and one previously reported (c.374_375delCT, p.Ser125*).
Conclusions
Germline CDKN1B pathogenic variants cause the syndrome Multiple Endocrine Neoplasia type 4. The phenotype resulting from the three pathogenic variants described in this series highlights the heterogenous nature of this syndrome, ranging from isolated primary hyperparathyroidism to the full spectrum of endocrine manifestations. We report the first described cases of a prolactinoma and an atypical thymic carcinoid tumor in MEN4.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.